Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Herpes zoster, Oropharyngeal pain, Urticaria, Viral infection
Clinical narrative: Bronchitis; Hair loss; COVID-19; Sore back; Shingles; Blister; Welts; Viral infection; Sore throat; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis), ALOPECIA (Hair loss), COVID-19 (COVID-19), BLISTER (Blister) and BACK PAIN (Sore back) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect products included non-company products UPADACITINIB (RINVOQ) for Rheumatoid arthritis and METHOTREXATE for an unknown indication.    Concurrent medical conditions included Rheumatoid arthritis.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Oral) at an unspecified dose and METHOTREXATE (unknown route) at an unspecified dose. In November 2021, the patient experienced VIRAL INFECTION (Viral infection), OROPHARYNGEAL PAIN (Sore throat) and COUGH (Coughing). In January 2022, the patient experienced BLISTER (Blister), HERPES ZOSTER (Shingles) and URTICARIA (Welts). On an unknown date, the patient experienced BRONCHITIS (Bronchitis), ALOPECIA (Hair loss), COVID-19 (COVID-19) and BACK PAIN (Sore back). The patient was treated with AZITHROMYCIN (Z-PAK) for Adverse event, at an unspecified dose and frequency. In December 2021, VIRAL INFECTION (Viral infection), OROPHARYNGEAL PAIN (Sore throat) and COUGH (Coughing) had resolved. At the time of the report, BRONCHITIS (Bronchitis) and ALOPECIA (Hair loss) had not resolved, COVID-19 (COVID-19), BLISTER (Blister), BACK PAIN (Sore back) and URTICARIA (Welts) outcome was unknown and HERPES ZOSTER (Shingles) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: (Positive) Positive.         Concomitant medication was not reported.  The patient had shingles shot vaccine about five years ago. She had some soreness in small of back, this hurt some after work and chores and was might be due to age and not her rheumatoid arthritis condition. She had lost hair around crown of her head, following Methotrexate medication, but she felt it was following having covid positive diagnosis. She was still losing hair. She had a real bad virus in Nov 2021 and had sore throat. She had Z-Pak antibiotic, then another stronger antibiotic. She also coughed head off with no fever, no congestion. She felt this might have covid again but not sure. She battled this for about three weeks. She had pain in right side near hip bone. She sat on heat pad for two days to aid this and had placed it on back. The heat pad had fluid in it and might have blistered her back. She had welts all over front stomach area and back. The physician diagnosed it as shingles across abdomen and through lower back. It was still sensitive around right hip, felt like sunburn when touched as of 11 Apr 2022. It was not an outbreak but sensitive area. She also had bronchitis but denied being in therapy.   It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.